Stay updated on Panitumumab, Nivolumab, Ipilimumab in mCRC Clinical Trial
Sign up to get notified when there's something new on the Panitumumab, Nivolumab, Ipilimumab in mCRC Clinical Trial page.

Latest updates to the Panitumumab, Nivolumab, Ipilimumab in mCRC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page's revision stamp was updated to v3.6.6, indicating a small release update to the page's documentation or formatting.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedRevision label updated from v3.6.4 to v3.6.5, indicating a new site build. This update is a maintenance/build change and does not indicate alterations to the study details or visible content.SummaryDifference0.1%

- Check43 days agoChange DetectedThe page’s revision tag was updated from v3.6.3 to v3.6.4, indicating a new build of the page. This change does not modify the visible study information.SummaryDifference0.1%

- Check65 days agoChange DetectedThe study documents revision was updated from v3.6.2 to v3.6.3, reflecting a new version of the Study Protocol and Statistical Analysis Plan.SummaryDifference0.1%

- Check72 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2. This indicates a minor update to the study record documentation.SummaryDifference0.1%

- Check86 days agoChange DetectedNew guidance and help sections have been added (How to Read a Study Record, Common Questions, How to Join a Study), along with a note that recruitment is no longer open to participants. The Interventions section label has been updated, and the site revision has advanced to v3.6.0, replacing v3.5.5.SummaryDifference0.4%

Stay in the know with updates to Panitumumab, Nivolumab, Ipilimumab in mCRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Panitumumab, Nivolumab, Ipilimumab in mCRC Clinical Trial page.